Patrick Dillon, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Focused Ultrasound and Gemcitabine in Breast Cancer (NCT04796220) | Patrick Dillon, MD | 2022-01-27 |
| Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer (NCT03237572) | Patrick Dillon, MD | 2017-09-25 |
Track Patrick Dillon, MD automatically
Every clearance here is in the API, with alerts when new ones post.